ArticleInternational journal of general medicine2026
Development and Internal Validation of a Risk Prediction Model for Visual Impairment Progression in Elderly Patients with Diabetic Retinopathy: A Single-Center Retrospective Study.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify predictors of visual impairment progression in elderly patients with diabetic retinopathy (DR) and to establish a risk prediction model. Methods: This single-center retrospective study included 443 elderly patients with DR treated between January 2022 and January 2025. According to the occurrence of visual impairment within 12 months after discharge, patients were divided into progression and non-progression groups. Multivariate logistic regression analysis was used to identify predictors, and a nomogram-based risk prediction model was constructed. Receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) were used to evaluate model performance. Results: Multivariate Logistic regression analysis demonstrated that duration of diabetes, educational level, duration of DR, presence of other underlying diseases, DR stage, baseline glycated hemoglobin (HbA1c), and vascular endothelial growth factor A (VEGFA) level were independently associated with visual impairment progression and were included as predictors in the final model. ROC curve analysis showed that the area under the curve (AUC) was 0.932 in the training cohort and 0.925 in the validation cohort, indicating good discriminative performance. Bootstrap validation demonstrated good agreement between the calibration curve and the ideal curve, and no significant difference was observed between the predicted and observed values in either cohort (χ Conclusion: Duration of diabetes, educational level, duration of DR, presence of other underlying diseases, DR stage, baseline HbA1c, and VEGFA levels were associated with visual impairment progression in elderly patients with DR. The nomogram demonstrated good discrimination and calibration in this single-center cohort; however, its performance may be optimistic because the validation cohort was derived from the same institution, and independent external validation is required before broader clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.